Post Profile






Related Posts


AstraZeneca to buy 55 percent of cancer firm Acerta for $4 billion

Business & Finance : Business Insider: Clusterstock

LONDON (Reuters) - AstraZeneca said on Thursday it had agreed to buy a 55 percent stake in privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will...

Biotech Stock Kite Phama Explodes Higher After Good News About Its Non-Hodgkin's Lymphoma Drug (KITE, IBB)

Business & Finance : Business Insider: Clusterstock

Shares of Kite Pharma are exploding higher in after-hours trading. The $827 million biotech firm just revealed positive outcomes from patients with aggressive non-Hodgkin's lymphoma after receiving its anti-CD19 treatment. KITE is u...

Pfizer to invest $350 million in China biotech hub, first in Asia

Business & Finance : Business Insider: Clusterstock

SHANGHAI (Reuters) - Pfizer Inc will invest $350 million to build a biotech center in China, the latest in a series of moves by pharma industry giants to set up shop in the world's no. 2 drugs market with the aim of securing faster ...

More Pain For Biotechs Ahead: Valeant's "Astronomical" Price Increases Take Center Stage; Pfizer Gets Dragged In

Business & Finance : Zero Hedge

Two weeks ago, the biotech sector imploded after a piece by the NYT'a Andrew Pollack drew attention to the 5000% increase in the price of a toxoplasmosis drug by specialty biotech firm Turing Pharma, whose CEO Martin Shkreli promptl...

A Big-Name US Biotech Firm Is Going On A $1 Billion Spending Spree

Business & Finance : Business Insider: Clusterstock

Event US biotech firm AbbVie is to team up with Infinity Pharmaceuticals, a US pharma company, investing US$800m to develop a promising blood cancer drug. The company is also funnelling US$250m into a joint research partnership with...

Comments


Copyright © 2016 Regator, LLC